Neudata research | Lend-Rx Technology

Lend-Rx Technology

Visit website

Request report Claim this profile

Lend-Rx Technology is attending the

[]

About Lend-Rx Technology

DDQ available

For anyone involved or investing in the Healthcare Sector, Lend-Rx Technology produces extensive Alternative Data providing a unique insight on therapeutics in R&D and early stage of launch and their related companies, thanks to a bottom-up approach capturing the leading trends of the sector through the specialists' voice in the social networks and capitalizing on a deep industry knowledge and a strong data science expertise.

Lend-Rx Technology products

On chain data

New today

Request information

[{"title":"Pharmaceutical news catalysts data","url":"https://www.neudata.co/datasets/pharmaceutical-news-catalysts-data","publication_flag":null},{"title":"Clinical Trial Data","url":"https://www.neudata.co/datasets/lend-rxtrials","publication_flag":null},{"title":"Therapeutics social media data and analytics","url":"https://www.neudata.co/datasets/pharmaceutical-pipeline-social-media-analytics","publication_flag":null},{"title":"Therapeutic intelligence platform","url":"https://www.neudata.co/additional-datasets/therapeutic-intelligence-platform","publication_flag":null}]

Similar vendors to Lend-Rx Technology

Neudata has identified 18 vendors that have similar offerings to Lend-Rx Technology. Request the full report to find out more.

Advanced Technologies

Quality Assurance

Essential Supplies

NextGen Services

Innovative Strategies

Synergy Partners

Pioneer Solutions

Urban Developments

Noble Ventures

Visionary Concepts

Elite Marketing

Prime Consulting

Future Tech

Bright Ideas

Dynamic Systems

Global Services

Creative Designs

Smart Logistics

Green Innovations

Tech Solutions

News and intelligence related to Lend-Rx Technology

[{"title":"Update: 10 data products that might not survive 2024","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdk5XIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--f3214a0bc2abe2c0b64b645b29778dd73b0dc4af/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/jr-korpa-k9TDpGMDavs-unsplash.jpg","url":"https://www.neudata.co/intelligence/update-10-data-products-that-might-not-survive-2024","publication_date":"2024-12-23","category":"Intelligence"},{"title":"10 data products that might not survive 2024","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdUZMIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--59c5d91076c65383414263b0b68012de46ea11b4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/pexels-gantas-vaiciulenas.jpg","url":"https://www.neudata.co/intelligence/10-data-products-that-might-not-survive-2024","publication_date":"2024-01-31","category":"Intelligence"},{"title":"Money meets medicine: The private equity prescription for alternative healthcare data","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBc2hLIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--6f0e79dbaa8e95280adccac08cdfa20b2efcf885/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/christine-sandu-jwWtZrm67VI-unsplash.jpg","url":"https://www.neudata.co/intelligence/money-meets-medicine-the-private-equity-prescription-for-alternative-healthcare-data","publication_date":"2024-01-10","category":"Intelligence"},{"title":"Healthcare revisited – A quick 2023 bird’s-eye view","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBc3BLIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--2546ed8339bb6683b746f3e0adc4cec181a8ea4e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZ3pNVEVHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--b55e821fff1fb6a5277a641f9807539f25cc39cc/christina-victoria-craft-ZHys6xN7sUE-unsplash.jpg","url":"https://www.neudata.co/intelligence/healthcare-revisited-a-quick-2023-birds-eye-view","publication_date":"2023-09-27","category":"Intelligence"},{"title":"Twitter and Reddit changes raise social media data risk","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBamhMIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--186e9c99f324c650b0ee07a1ab6f57b033a12ff9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZ3pNVEVHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--b55e821fff1fb6a5277a641f9807539f25cc39cc/Reddit-photo-.jpg","url":"https://www.neudata.co/intelligence/twitter-and-reddit-changes-raise-social-media-data-risk","publication_date":"2023-07-19","category":"Intelligence"},{"title":"Event recap: Healthcare claims, drug trial data help investors determine COVID-19 impact","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdHhFIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--931e4dd5035259dce61f6551b056c9c5d6f207cf/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/henrik-donnestad-t2Sai-AqIpI-unsplash.jpg","url":"https://www.neudata.co/alternative-data-news/event-recap-healthcare-claims-drug-trial-data-help-investors-determine-covid-19-impact","publication_date":"2020-11-02","category":"News"},{"title":"Monitoring equities through social media data","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBanhMIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--4441a003f796fb73143e74383d207f70a3422b4b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZ3pNVEVHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--b55e821fff1fb6a5277a641f9807539f25cc39cc/royalty-free-header-image.jpg","url":"https://www.neudata.co/intelligence/monitoring-equities-through-social-media-data","publication_date":"2020-08-05","category":"Intelligence"},{"title":"COVID-19: 11 ways to assess the healthcare sector","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBbmhMIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--46945be9318f2c641710d00f6300b330a9baa780/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZ3pNVEVHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--b55e821fff1fb6a5277a641f9807539f25cc39cc/covid-19-healthcare-intelligence-header-image.jpg","url":"https://www.neudata.co/intelligence/covid-19-11-ways-to-assess-the-healthcare-sector","publication_date":"2020-04-23","category":"Intelligence"},{"title":"Alternative Data for Healthcare Investors (Part III): Clinical Trial Datasets","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBc1JLIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--74c18ffd4727d00d4a79028298a612652bead929/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/haley-lawrence-HTttz00wkzU-unsplash.jpg","url":"https://www.neudata.co/intelligence/alternative-data-for-healthcare-investors-part-iii-clinical-trial-datasets","publication_date":"2019-07-11","category":"Intelligence"},{"title":"Alternative Data for Healthcare Investors (Part II): Predicting Clinical Trial Outcomes","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBc05LIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--310850a07118e2dbcaaaa933c9dd0a6d274a1975/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/header-image-partII1.jpg","url":"https://www.neudata.co/intelligence/alternative-data-for-healthcare-investors-part-ii-predicting-clinical-trial-outcomes","publication_date":"2019-04-11","category":"Intelligence"},{"title":"Alternative Data for Healthcare Investors (Part I): A Primer on Real-World Data","image":"https://www.neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBckpMIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--ee0bcefbb716c95505b7a0536284a57952d7e181/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/header-option-1-aerial-view-application-935869-1.jpg","url":"https://www.neudata.co/intelligence/alternative-data-for-healthcare-investors-part-i-a-primer-on-real-world-data","publication_date":"2019-03-14","category":"Intelligence"}]

Lend-Rx Technology risk check

Dataset type(s) - select all that apply.

Please highlight any of the following components that may be included in your categories selected above (Personal data, location data, demographic data, or other sensitive data elements).

Please list the data products this assessment covers.

Mauris eu cursus odio, sit amet aliquam sem.

How long have you been selling data?

Donec tempor, libero non ultrices volutpat.

Please highlight any relevant litigation or negative press.

Phasellus dolor tellus.

How many financial services firms are using your data (excluding corporate users and unpaid trialists)?

Cras mattis, turpis sit amet volutpat viverra.

Request access

["Fundamental","News","Sentiment","Social Media"]

About Neudata

Neudata provides unbiased research and expert consultancy on data sources and use cases. We connect data buyers and sellers through our platform, creating efficiencies for people who work with data.

Our platform includes in-depth research on thousands of data vendors, which are evaluated on over 100 unique factors to ensure their usability for data buyers.

Data buyers: Discover, manage, stay ahead

We exist to simplify the complex world of data discovery. By guiding investment teams through sourcing, trialling and managing data, we empower them to focus on what they do best – generating alpha.

Let's get started

Are you Lend-Rx Technology?

Take control of your Neudata profile to ensure accurate representation of your data offerings and maximise visibility with qualified buyers in the investment space.

Claim your profile

Request a full version of this report

Neudata publishes in-depth research on data vendor products and offerings, including information on pricing and the competitive landscape. Fill out your details below to request a full version of this research report.

Founded

2018

Company history

From day one Lend-Rx Technology is focusing on enabling the product's knowledge of its founder with the data science and financial expertise of its partners to build powerful alternative data. Lend-Rx Technology started to commercialise its datasets toward Quant Hedge Funds and has several subscribers to its datasets Lend-Rx Tech commercialise a full array of datasets on Therapeutics, LendRx Listener Therapeutics, LendRx Listener_Signals, LendRx_Mappy Lend-Rx recently lunch a SaaS platform, Doltracker, for fundamental investors in both public and private healthcare companies.

Office locations

Paris

Number of employees

Sources of funding

Private Investors

Contact name

John Smith

Contact role

Analyst